Merck director granted 63 phantom stock units
Seidman Christine E reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Seidman Christine E reported acquisition or exercise transactions in this Form 4 filing.
Merck & Co., Inc. director Christine E. Seidman reported a routine compensation-related award of 63.2296 phantom stock units on June 30, 2026 at a reference value of $128.5000 per unit, increasing her phantom stock balance to 21,291.2690 units. She also reported direct ownership of 100 shares of common stock. The phantom stock units are cash-settled on a 1-for-1 basis in accordance with Merck’s deferred compensation plan after her service ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 63.2296 shares
Grant/Award
2 txns
Insider
Seidman Christine E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock | 63.2296 | $128.50 | $8K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Phantom Stock — 21,291.269 contracts (Direct);
Common Stock — 100 shares (Direct)
Footnotes (2)
- F1. 1-for-1
- F2. Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
Key Figures
Phantom stock grant: 63.2296 units
Reference price per unit: $128.5000 per unit
Total phantom units after grant: 21,291.2690 units
+2 more
5 metrics
Phantom stock grant
63.2296 units
Grant to director on June 30, 2026
Reference price per unit
$128.5000 per unit
Phantom stock unit value for the grant
Total phantom units after grant
21,291.2690 units
Director’s phantom stock balance post-transaction
Common stock held
100 shares
Direct Merck common stock ownership
Settlement ratio
1-for-1
Phantom units linked 1-for-1 with common stock
Key Terms
Phantom Stock, Plan for Deferred Payment of Directors' Compensation, Grant, award, or other acquisition, phantom stock units are to be settled 100% in cash
4 terms
Phantom Stock financial
"Phantom Stock units are to be settled 100% in cash upon reporting person's termination of service"
A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.
Plan for Deferred Payment of Directors' Compensation financial
"in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
phantom stock units are to be settled 100% in cash financial
"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Merck (MRK) report for Christine E. Seidman?
Merck director Christine E. Seidman received 63.2296 phantom stock units as a grant. These units are part of a deferred compensation plan and mirror Merck’s common stock value, representing compensation rather than an open-market share purchase or sale.
How many Merck phantom stock units does Christine E. Seidman now hold?
After the June 30, 2026 grant, Christine E. Seidman holds 21,291.2690 phantom stock units. These units are tied to Merck’s common stock value and are scheduled to be settled in cash after her service ends, following the plan’s distribution schedule.
How are Merck phantom stock units for directors settled under the plan?
Merck’s phantom stock units for directors are settled 100% in cash after service termination. The units are credited on a 1-for-1 basis with Merck common stock and paid out according to a distribution schedule elected under the Plan for Deferred Payment of Directors’ Compensation.
What Merck common stock holdings does Christine E. Seidman report after this Form 4?
Christine E. Seidman reports direct ownership of 100 shares of Merck common stock. This is separate from her 21,291.2690 phantom stock units, which are cash-settled compensation instruments linked to Merck’s stock value rather than actual issued shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
